Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

Brain Pathology

Volumn 23, Issue 5, 2013, Pages 584-594

  Raghunathan, Aditya ^a   Wani, Khalida ^a   Armstrong, Terri S ^a   Vera Bolanos, Elizabeth ^a   Fouladi, Maryam ^b   Gilbertson, Richard ^c   Gajjar, Amar ^c   Goldman, Stewart ^d   Lehman, Norman L ^e   Metellus, Phillipe ^f   Mikkelsen, Tom ^e   Necesito Reyes, Mary Jo T ^a   Omuro, Antonio ^g   Packer, Roger J ^h   Partap, Sonia ⁱ   Pollack, Ian F ^j   Prados, Michael D ^k   Robins, H Ian ^l   Soffietti, Riccardo ^m   Wu, Jing ⁿ   Miller, C Ryan ⁿ   Gilbert, Mark R ^a   Aldape, Kenneth D ^a   more..

^a UNIVERSITY OF TEXAS   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HENRY FORD HOSPITAL   (United States)

^f TIMONE HOSPITAL   (France)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ STANFORD UNIVERSITY   (United States)

^j CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^m UNIVERSITY OF TURIN   (Italy)

ⁿ UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

Ependymoma; histology; progression free survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CHILD; EPENDYMOMA; FOLLOW UP; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; INFANT; MAJOR CLINICAL STUDY; MITOSIS RATE; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; SCHOOL CHILD; TUMOR LOCALIZATION; TUMOR NECROSIS; TUMOR RECURRENCE;

EPENDYMOMA; HISTOLOGY; PROGRESSION-FREE SURVIVAL;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; YOUNG ADULT;

EID: 84882256105     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12050     Document Type: Article

References (24)

1. Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME, (2012) Predictors of survival among older adults with ependymoma. J Neurooncol 107: 183-189.
2. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, et al (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 86: 929-939.
3. Ernestus RI, Schroder R, Stutzer H, Klug N, (1996) Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Childs Nerv Syst 12: 522-526.
4. Figarella-Branger D, Civatte M, Bouvier-Labit C, Gouvernet J, Gambarelli D, Gentet JC, et al (2000) Prognostic factors in intracranial ependymomas in children. J Neurosurg 93: 605-613.
5. Gilbert MR, Ruda R, Soffietti R, (2010) Ependymomas in adults. Curr Neurol Neurosci Rep 10: 240-247.
6. Godfraind C, Kaczmarska JM, Kocak M, Dalton J, Wright KD, Sanford RA, et al (2012) Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas. Acta Neuropathol 124: 247-257.
7. Guyotat J, Metellus P, Giorgi R, Barrie M, Jouvet A, Fevre-Montange M, et al (2009) Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) 151: 947-960.
8. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, et al (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466: 632-636.
9. Kawabata Y, Takahashi JA, Arakawa Y, Hashimoto N, (2005) Long-term outcome in patients harboring intracranial ependymoma. J Neurosurg 103: 31-37.
10. Kilday JP, Mitra B, Domerg C, Ward J, Andreiuolo F, Osteso-Ibanez T, et al (2012) Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP). Clin Cancer Res 18: 2001-2011.
11. Korshunov A, Ryzhova M, Jones DT, Northcott PA, van, Sluis P, Volckmann R, et al (2012) LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 124: 875-881.
12. Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, et al (2010) Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28: 3182-3190.
13. McGuire CS, Sainani KL, Fisher PG, (2009) Both location and age predict survival in ependymoma: a SEER study. Pediatr Blood Cancer 52: 65-69.
14. McGuire CS, Sainani KL, Fisher PG, (2009) Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg 110: 725-729.
15. Metellus P, Figarella-Branger D, Guyotat J, Barrie M, Giorgi R, Jouvet A, Chinot O, (2008) Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients. Cancer 113: 175-185.
16. Metellus P, Guyotat J, Chinot O, Durand A, Barrie M, Giorgi R, et al (2010) Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. Neuro Oncol 12: 976-984.
17. Oya N, Shibamoto Y, Nagata Y, Negoro Y, Hiraoka M, (2002) Postoperative radiotherapy for intracranial ependymoma: analysis of prognostic factors and patterns of failure. J Neurooncol 56: 87-94.
18. Paulino AC, Wen BC, (2000) The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys 47: 585-589.
19. Rogers HA, Kilday JP, Mayne C, Ward J, Adamowicz-Brice M, Schwalbe EC, et al (2012) Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death. Acta Neuropathol 123: 711-725.
20. Schneider D, Monoranu CM, Huang B, Rutkowski S, Gerber NU, Krauss J, et al (2009) Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis. Cancer Genet Cytogenet 191: 90-96.
21. Tihan T, Zhou T, Holmes E, Burger PC, Ozuysal S, Rushing EJ, (2008) The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors. Mod Pathol 21: 165-177.
22. Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, et al (2012) A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123: 727-738.
23. Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20: 143-157.
24. Zhu H, Shyh-Chang N, Segre AV, Shinoda G, Shah SP, Einhorn WS, et al (2011) The Lin28/let-7 axis regulates glucose metabolism. Cell 147: 81-94.